Sensirion founders win Entrepreneur of the Year Award
Recognised for their innovation, flexibility and willingness to take risks
The Award is given to successful entrepreneurs who combine personal commitment and risk-taking to help strengthen the competitiveness of the Swiss economy.
Sensirion was set up in 1998 as a spin-off from ETH Zurich and has since established itself as a leading hi-tech company developing humidity- and temperature sensors, mass flow controllers, flow sensors for gases and fluids, as well as differential pressure sensors.
Headquartered near Zurich, it now employs more than 200 people and also has offices in the US, Japan, South Korea and China.
Describing Sensirion as ‘solid, consistent, innovative, cosmopolitan and still modest’, the judges also said the firm’s distinctive corporate culture had contributed to its success.
‘Winning the Entrepreneur of the Year 2010 Award is for us, both confirmation and motivation to serve our customers time and again with innovative and requirement-oriented sensor solutions,’ said Lechner.
Bruno Chiomento, chief executive of Ernst & Young Switzerland, said despite the difficult economic environment, entrepreneurship in Switzerland is in full bloom. He said the winners had been successful because of their innovation, flexibility and willingness to take risks.
You may also like
Manufacturing
LYOVAC® ECO Mode: making pharmaceutical freeze-drying leaner and greener
Following the recent announcement that GEA Lyophil has received third-party certification for the energy-saving credentials of its innovative algorithm for freeze-drying applications, Dr Kevin Robinson caught up with Senior Director of Lyophilization Technology Management, Thomas Beutler, to find out more
Manufacturing
Particology joins £8.2m consortium to drive greener, more efficient medicines manufacturing
The company has been selected for Innovate UK’s £54m Sustainable Medicines Manufacturing Innovation Programme, leading crystallisation research to cut waste, reduce energy use and accelerate next-generation pharmaceutical production